Company / Operating Income per Share
Fortress Biotech, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.95
FY2025
5-year range
-$27.63 / -$0.99
FY2021-FY2025
Trend
+58.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 10 years, ranging from $-27.63 in FY2023 to $-0.44 in FY2016.
Based on SEC 10-K filings.
-3.95 in FY2025.
Improved from $-27.63 to $-3.95 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 58.1% year-over-year.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.95 | +58.1% |
| FY2024 | -$9.43 | +65.9% |
| FY2023 | -$27.63 | -1386.7% |
| FY2022 | -$1.86 | -87.1% |
| FY2021 | -$0.99 | +33.6% |
| FY2020 | -$1.50 | +27.8% |
| FY2019 | -$2.07 | -17.8% |
| FY2018 | -$1.76 | -70.5% |
| FY2017 | -$1.03 | -135.8% |
| FY2016 | -$0.44 | +43.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026